nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0923	0.119	CbGbCtD
Carbinoxamine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0681	0.0875	CbGbCtD
Carbinoxamine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0681	0.0875	CbGbCtD
Carbinoxamine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0615	0.079	CbGbCtD
Carbinoxamine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0566	0.0727	CbGbCtD
Carbinoxamine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0566	0.0727	CbGbCtD
Carbinoxamine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0518	0.0665	CbGbCtD
Carbinoxamine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0518	0.0665	CbGbCtD
Carbinoxamine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0461	0.0593	CbGbCtD
Carbinoxamine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0434	0.0558	CbGbCtD
Carbinoxamine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0429	0.0551	CbGbCtD
Carbinoxamine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0293	0.0377	CbGbCtD
Carbinoxamine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0286	0.0367	CbGbCtD
Carbinoxamine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.028	0.036	CbGbCtD
Carbinoxamine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0249	0.0321	CbGbCtD
Carbinoxamine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0146	0.0188	CbGbCtD
Carbinoxamine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0138	0.0178	CbGbCtD
Carbinoxamine—Epigastric distress—Salbutamol—chronic obstructive pulmonary disease	0.00468	0.0315	CcSEcCtD
Carbinoxamine—Extrasystoles—Aminophylline—chronic obstructive pulmonary disease	0.003	0.0202	CcSEcCtD
Carbinoxamine—Extrasystoles—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.0153	CcSEcCtD
Carbinoxamine—Extrasystoles—Formoterol—chronic obstructive pulmonary disease	0.00228	0.0153	CcSEcCtD
Carbinoxamine—Extrasystoles—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.0145	CcSEcCtD
Carbinoxamine—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.0138	CcSEcCtD
Carbinoxamine—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00183	0.0123	CcSEcCtD
Carbinoxamine—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.0118	CcSEcCtD
Carbinoxamine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.0118	CcSEcCtD
Carbinoxamine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.0117	CcSEcCtD
Carbinoxamine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.011	CcSEcCtD
Carbinoxamine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00162	0.0109	CcSEcCtD
Carbinoxamine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00161	0.0108	CcSEcCtD
Carbinoxamine—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.0105	CcSEcCtD
Carbinoxamine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.0104	CcSEcCtD
Carbinoxamine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00153	0.0103	CcSEcCtD
Carbinoxamine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.0103	CcSEcCtD
Carbinoxamine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.01	CcSEcCtD
Carbinoxamine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00983	CcSEcCtD
Carbinoxamine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00972	CcSEcCtD
Carbinoxamine—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00937	CcSEcCtD
Carbinoxamine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00877	CcSEcCtD
Carbinoxamine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00845	CcSEcCtD
Carbinoxamine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00821	CcSEcCtD
Carbinoxamine—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00799	CcSEcCtD
Carbinoxamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00789	CcSEcCtD
Carbinoxamine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00783	CcSEcCtD
Carbinoxamine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00115	0.00776	CcSEcCtD
Carbinoxamine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00748	CcSEcCtD
Carbinoxamine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00745	CcSEcCtD
Carbinoxamine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00728	CcSEcCtD
Carbinoxamine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00721	CcSEcCtD
Carbinoxamine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00721	CcSEcCtD
Carbinoxamine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00708	CcSEcCtD
Carbinoxamine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00695	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00694	CcSEcCtD
Carbinoxamine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00682	CcSEcCtD
Carbinoxamine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.00682	CcSEcCtD
Carbinoxamine—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00681	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000994	0.00669	CcSEcCtD
Carbinoxamine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00098	0.00659	CcSEcCtD
Carbinoxamine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000975	0.00656	CcSEcCtD
Carbinoxamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000968	0.00651	CcSEcCtD
Carbinoxamine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00643	CcSEcCtD
Carbinoxamine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000924	0.00621	CcSEcCtD
Carbinoxamine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000919	0.00618	CcSEcCtD
Carbinoxamine—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000893	0.00601	CcSEcCtD
Carbinoxamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000893	0.006	CcSEcCtD
Carbinoxamine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000878	0.00591	CcSEcCtD
Carbinoxamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000858	0.00577	CcSEcCtD
Carbinoxamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000858	0.00577	CcSEcCtD
Carbinoxamine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.00571	CcSEcCtD
Carbinoxamine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000846	0.00569	CcSEcCtD
Carbinoxamine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000841	0.00566	CcSEcCtD
Carbinoxamine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000828	0.00557	CcSEcCtD
Carbinoxamine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000824	0.00554	CcSEcCtD
Carbinoxamine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.00554	CcSEcCtD
Carbinoxamine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000817	0.0055	CcSEcCtD
Carbinoxamine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000815	0.00548	CcSEcCtD
Carbinoxamine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000815	0.00548	CcSEcCtD
Carbinoxamine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000814	0.00548	CcSEcCtD
Carbinoxamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000802	0.00539	CcSEcCtD
Carbinoxamine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00533	CcSEcCtD
Carbinoxamine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000786	0.00529	CcSEcCtD
Carbinoxamine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000786	0.00529	CcSEcCtD
Carbinoxamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000782	0.00526	CcSEcCtD
Carbinoxamine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00523	CcSEcCtD
Carbinoxamine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000771	0.00519	CcSEcCtD
Carbinoxamine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000771	0.00519	CcSEcCtD
Carbinoxamine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00077	0.00518	CcSEcCtD
Carbinoxamine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00077	0.00518	CcSEcCtD
Carbinoxamine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00516	CcSEcCtD
Carbinoxamine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000762	0.00513	CcSEcCtD
Carbinoxamine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000756	0.00508	CcSEcCtD
Carbinoxamine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.00503	CcSEcCtD
Carbinoxamine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000743	0.005	CcSEcCtD
Carbinoxamine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00499	CcSEcCtD
Carbinoxamine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00499	CcSEcCtD
Carbinoxamine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000728	0.0049	CcSEcCtD
Carbinoxamine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00489	CcSEcCtD
Carbinoxamine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000726	0.00488	CcSEcCtD
Carbinoxamine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000715	0.00481	CcSEcCtD
Carbinoxamine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000712	0.00479	CcSEcCtD
Carbinoxamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00479	CcSEcCtD
Carbinoxamine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00471	CcSEcCtD
Carbinoxamine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000674	0.00454	CcSEcCtD
Carbinoxamine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000669	0.0045	CcSEcCtD
Carbinoxamine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000669	0.0045	CcSEcCtD
Carbinoxamine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.00066	0.196	CrCbGaD
Carbinoxamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000657	0.00442	CcSEcCtD
Carbinoxamine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000649	0.00437	CcSEcCtD
Carbinoxamine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00431	CcSEcCtD
Carbinoxamine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00431	CcSEcCtD
Carbinoxamine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000636	0.00428	CcSEcCtD
Carbinoxamine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00425	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000625	0.00421	CcSEcCtD
Carbinoxamine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.00417	CcSEcCtD
Carbinoxamine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00062	0.00417	CcSEcCtD
Carbinoxamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00415	CcSEcCtD
Carbinoxamine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000616	0.00414	CcSEcCtD
Carbinoxamine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000609	0.0041	CcSEcCtD
Carbinoxamine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000609	0.0041	CcSEcCtD
Carbinoxamine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00408	CcSEcCtD
Carbinoxamine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00407	CcSEcCtD
Carbinoxamine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00406	CcSEcCtD
Carbinoxamine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00406	CcSEcCtD
Carbinoxamine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000603	0.00405	CcSEcCtD
Carbinoxamine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000597	0.00401	CcSEcCtD
Carbinoxamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000595	0.004	CcSEcCtD
Carbinoxamine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00397	CcSEcCtD
Carbinoxamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000591	0.00397	CcSEcCtD
Carbinoxamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000591	0.00397	CcSEcCtD
Carbinoxamine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000586	0.00394	CcSEcCtD
Carbinoxamine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000586	0.00394	CcSEcCtD
Carbinoxamine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00394	CcSEcCtD
Carbinoxamine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000581	0.00391	CcSEcCtD
Carbinoxamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00389	CcSEcCtD
Carbinoxamine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000575	0.00387	CcSEcCtD
Carbinoxamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000572	0.00385	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00057	0.00384	CcSEcCtD
Carbinoxamine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00383	CcSEcCtD
Carbinoxamine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.0038	CcSEcCtD
Carbinoxamine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000565	0.0038	CcSEcCtD
Carbinoxamine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000564	0.00379	CcSEcCtD
Carbinoxamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00378	CcSEcCtD
Carbinoxamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.00378	CcSEcCtD
Carbinoxamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000558	0.00375	CcSEcCtD
Carbinoxamine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00372	CcSEcCtD
Carbinoxamine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000544	0.00366	CcSEcCtD
Carbinoxamine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000544	0.00366	CcSEcCtD
Carbinoxamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00363	CcSEcCtD
Carbinoxamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000535	0.0036	CcSEcCtD
Carbinoxamine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000533	0.00359	CcSEcCtD
Carbinoxamine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.00359	CcSEcCtD
Carbinoxamine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000532	0.00358	CcSEcCtD
Carbinoxamine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00352	CcSEcCtD
Carbinoxamine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000514	0.00346	CcSEcCtD
Carbinoxamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000504	0.00339	CcSEcCtD
Carbinoxamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00331	CcSEcCtD
Carbinoxamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00331	CcSEcCtD
Carbinoxamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00324	CcSEcCtD
Carbinoxamine—Chlorphenamine—SLC6A4—chronic obstructive pulmonary disease	0.000471	0.14	CrCbGaD
Carbinoxamine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00315	CcSEcCtD
Carbinoxamine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00315	CcSEcCtD
Carbinoxamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00312	CcSEcCtD
Carbinoxamine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000462	0.00311	CcSEcCtD
Carbinoxamine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000459	0.00309	CcSEcCtD
Carbinoxamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00305	CcSEcCtD
Carbinoxamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00305	CcSEcCtD
Carbinoxamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00298	CcSEcCtD
Carbinoxamine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00298	CcSEcCtD
Carbinoxamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00293	CcSEcCtD
Carbinoxamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00293	CcSEcCtD
Carbinoxamine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.00289	CcSEcCtD
Carbinoxamine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000429	0.00289	CcSEcCtD
Carbinoxamine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00288	CcSEcCtD
Carbinoxamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00288	CcSEcCtD
Carbinoxamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00287	CcSEcCtD
Carbinoxamine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00283	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00279	CcSEcCtD
Carbinoxamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00277	CcSEcCtD
Carbinoxamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000408	0.00275	CcSEcCtD
Carbinoxamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00274	CcSEcCtD
Carbinoxamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00274	CcSEcCtD
Carbinoxamine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00273	CcSEcCtD
Carbinoxamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00268	CcSEcCtD
Carbinoxamine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.00265	CcSEcCtD
Carbinoxamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00258	CcSEcCtD
Carbinoxamine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.00244	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00241	CcSEcCtD
Carbinoxamine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000354	0.105	CrCbGaD
Carbinoxamine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.00226	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000333	0.00224	CcSEcCtD
Carbinoxamine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000322	0.0958	CrCbGaD
Carbinoxamine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00209	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.00206	CcSEcCtD
Carbinoxamine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00204	CcSEcCtD
Carbinoxamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000297	0.002	CcSEcCtD
Carbinoxamine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00198	CcSEcCtD
Carbinoxamine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000291	0.0866	CrCbGaD
Carbinoxamine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00193	CcSEcCtD
Carbinoxamine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000272	0.0809	CrCbGaD
Carbinoxamine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.00027	0.0805	CrCbGaD
Carbinoxamine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00177	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00175	CcSEcCtD
Carbinoxamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00173	CcSEcCtD
Carbinoxamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00165	CcSEcCtD
Carbinoxamine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00164	CcSEcCtD
Carbinoxamine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000242	0.00163	CcSEcCtD
Carbinoxamine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000237	0.0016	CcSEcCtD
Carbinoxamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00158	CcSEcCtD
Carbinoxamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00156	CcSEcCtD
Carbinoxamine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00156	CcSEcCtD
Carbinoxamine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00155	CcSEcCtD
Carbinoxamine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000222	0.00149	CcSEcCtD
Carbinoxamine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.0657	CrCbGaD
Carbinoxamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00148	CcSEcCtD
Carbinoxamine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00144	CcSEcCtD
Carbinoxamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.0013	CcSEcCtD
Carbinoxamine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000186	0.0555	CrCbGaD
Carbinoxamine—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000186	0.0553	CrCbGaD
Carbinoxamine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000184	0.00124	CcSEcCtD
Carbinoxamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000178	0.0012	CcSEcCtD
Carbinoxamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00115	CcSEcCtD
Carbinoxamine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00114	CcSEcCtD
Carbinoxamine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000163	0.00233	CbGpPWpGaD
Carbinoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000162	0.00231	CbGpPWpGaD
Carbinoxamine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000161	0.00231	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000161	0.0023	CbGpPWpGaD
Carbinoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00229	CbGpPWpGaD
Carbinoxamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00108	CcSEcCtD
Carbinoxamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00228	CbGpPWpGaD
Carbinoxamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00228	CbGpPWpGaD
Carbinoxamine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00226	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000149	0.00213	CbGpPWpGaD
Carbinoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00208	CbGpPWpGaD
Carbinoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00205	CbGpPWpGaD
Carbinoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00204	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000141	0.00201	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000139	0.00199	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000138	0.00198	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00197	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00195	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00193	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00191	CbGpPWpGaD
Carbinoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00188	CbGpPWpGaD
Carbinoxamine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00187	CbGpPWpGaD
Carbinoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00186	CbGpPWpGaD
Carbinoxamine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	0.000128	0.038	CrCbGaD
Carbinoxamine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000125	0.00179	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000124	0.00177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.00169	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000117	0.00167	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00167	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000115	0.00165	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00165	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000115	0.00165	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000114	0.00164	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000114	0.00163	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000114	0.00162	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000113	0.00162	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000113	0.00161	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000111	0.00159	CbGpPWpGaD
Carbinoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00151	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000106	0.00151	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000105	0.00151	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000105	0.0015	CbGpPWpGaD
Carbinoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00148	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00147	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000102	0.00146	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000102	0.00146	CbGpPWpGaD
Carbinoxamine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000101	0.00145	CbGpPWpGaD
Carbinoxamine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00143	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.89e-05	0.00141	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.88e-05	0.00141	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.82e-05	0.0014	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.74e-05	0.00139	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.69e-05	0.00138	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.61e-05	0.00137	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.59e-05	0.00137	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.51e-05	0.00136	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.46e-05	0.00135	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.38e-05	0.00134	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	9.16e-05	0.00131	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.95e-05	0.00128	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.83e-05	0.00126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.82e-05	0.00126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.7e-05	0.00124	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	8.68e-05	0.00124	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.63e-05	0.00123	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.58e-05	0.00123	CbGpPWpGaD
Carbinoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.58e-05	0.00123	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.49e-05	0.00121	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.37e-05	0.0012	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	8.07e-05	0.00115	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.04e-05	0.00115	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8e-05	0.00114	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.99e-05	0.00114	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.93e-05	0.00113	CbGpPWpGaD
Carbinoxamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	7.92e-05	0.00113	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	7.9e-05	0.00113	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.89e-05	0.00113	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.88e-05	0.00113	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.82e-05	0.00112	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	7.75e-05	0.00111	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00108	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.55e-05	0.00108	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.47e-05	0.00107	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.46e-05	0.00107	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.38e-05	0.00106	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.35e-05	0.00105	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.29e-05	0.00104	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.25e-05	0.00104	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.19e-05	0.00103	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.97e-05	0.000996	CbGpPWpGaD
Carbinoxamine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.91e-05	0.000988	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.87e-05	0.000983	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	6.83e-05	0.000976	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.81e-05	0.000974	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	6.78e-05	0.00097	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	6.71e-05	0.000959	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	6.61e-05	0.000945	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.27e-05	0.000897	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.18e-05	0.000884	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.1e-05	0.000872	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.95e-05	0.000851	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.9e-05	0.000844	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.61e-05	0.000802	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.56e-05	0.000795	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.41e-05	0.000773	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.34e-05	0.000764	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.23e-05	0.000748	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.23e-05	0.000748	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.23e-05	0.000747	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	5.2e-05	0.000743	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.17e-05	0.000739	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.16e-05	0.000738	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	5.09e-05	0.000728	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.87e-05	0.000696	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.83e-05	0.000691	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.81e-05	0.000687	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.74e-05	0.000678	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.73e-05	0.000677	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.56e-05	0.000651	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.52e-05	0.000647	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.49e-05	0.000643	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.49e-05	0.000641	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	4.4e-05	0.000629	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.35e-05	0.000621	CbGpPWpGaD
Carbinoxamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.19e-05	0.000599	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.14e-05	0.000591	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.09e-05	0.000585	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.04e-05	0.000577	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.000573	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.96e-05	0.000567	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.96e-05	0.000566	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.93e-05	0.000562	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.73e-05	0.000534	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.71e-05	0.000531	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.68e-05	0.000526	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.67e-05	0.000524	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.65e-05	0.000522	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.65e-05	0.000522	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.61e-05	0.000517	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.58e-05	0.000512	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.000485	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.36e-05	0.00048	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.34e-05	0.000477	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.33e-05	0.000476	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000466	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.19e-05	0.000457	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.19e-05	0.000456	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.18e-05	0.000455	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.000433	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.92e-05	0.000417	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.000416	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.84e-05	0.000406	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.81e-05	0.000401	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.78e-05	0.000398	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.75e-05	0.000393	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000379	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.000379	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.56e-05	0.000366	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.51e-05	0.000359	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.43e-05	0.000347	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.4e-05	0.000344	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	2.38e-05	0.00034	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.36e-05	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.36e-05	0.000337	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.33e-05	0.000334	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.000331	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.2e-05	0.000314	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.17e-05	0.00031	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.00031	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.15e-05	0.000307	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.12e-05	0.000303	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2e-05	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000283	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.97e-05	0.000282	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000281	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.96e-05	0.00028	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.95e-05	0.000279	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-05	0.000278	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000277	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.93e-05	0.000277	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.93e-05	0.000276	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.9e-05	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000259	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.000258	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000258	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.79e-05	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.78e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.77e-05	0.000253	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.76e-05	0.000252	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.00024	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000238	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.64e-05	0.000235	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.64e-05	0.000235	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000234	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.63e-05	0.000233	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.63e-05	0.000233	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.57e-05	0.000224	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.000219	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.49e-05	0.000213	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.47e-05	0.00021	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.46e-05	0.000208	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000208	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000196	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	0.000195	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.36e-05	0.000194	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000193	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.34e-05	0.000191	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000185	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	0.000185	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.28e-05	0.000182	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.00018	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.25e-05	0.000178	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.19e-05	0.00017	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000167	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000166	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.14e-05	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000153	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	9.87e-06	0.000141	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.67e-06	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	9.44e-06	0.000135	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.2e-06	0.000132	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.94e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.82e-06	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	8.81e-06	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.75e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	8.42e-06	0.00012	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.22e-06	0.000118	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	8.1e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.03e-06	0.000115	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.86e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.79e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.75e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.68e-06	0.00011	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.21e-06	0.000103	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.07e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.94e-06	8.49e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.43e-06	7.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.3e-06	7.57e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.07e-06	7.24e-05	CbGpPWpGaD
